Oral Etoposide in Treatment of Advanced Refractory Sarcomas

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JNCI : Journal of the National Cancer Institute 1992-12, Vol.84 (23), p.1836-1837
Hauptverfasser: KAMPE, CARSTEN E., LOWENBRAUN, SUSAN, FOSTER, JANE, ROSEN, GERALD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1837
container_issue 23
container_start_page 1836
container_title JNCI : Journal of the National Cancer Institute
container_volume 84
creator KAMPE, CARSTEN E.
LOWENBRAUN, SUSAN
FOSTER, JANE
ROSEN, GERALD
description
doi_str_mv 10.1093/jnci/84.23.1836
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73336428</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73336428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-4f7ab5cc49c03e0b33e5b907b6a73d015947923b0f9a02932eca10e7197496713</originalsourceid><addsrcrecordid>eNpFkE1LAzEQhoMotVbPnoQ9eds2yWQ3GzyVUq1YKLYVxEvIZmdh637UZCv237ulRecyh_eZF-Yh5JbRIaMKRpvaFqNEDDkMWQLxGekzEdOQMxqdkz6lXIZJIsUlufJ-Q7tRXPRIjwkAkKJPHhbOlMG0bbaNLzIMijpYOzRthXUbNHkwzr5NbTELlpg7Y9vG7YOVcbapjL8mF7kpPd6c9oC8PU7Xk1k4Xzw9T8bz0IJkbShyadLIWqEsBaQpAEapojKNjYSMskgJqTikNFeGcgUcrWEUJVNSqFgyGJD7Y-_WNV879K2uCm-xLE2Nzc5r2f0SC5504OgIWtd47zDXW1dUxu01o_qgSx906URoDvqgq7u4O1Xv0gqzf_7op8vDY174Fn_-YuM-dSxBRnr2_qFfV0uerGKuX-AXmeVz7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73336428</pqid></control><display><type>article</type><title>Oral Etoposide in Treatment of Advanced Refractory Sarcomas</title><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>KAMPE, CARSTEN E. ; LOWENBRAUN, SUSAN ; FOSTER, JANE ; ROSEN, GERALD</creator><creatorcontrib>KAMPE, CARSTEN E. ; LOWENBRAUN, SUSAN ; FOSTER, JANE ; ROSEN, GERALD</creatorcontrib><identifier>ISSN: 0027-8874</identifier><identifier>EISSN: 1460-2105</identifier><identifier>DOI: 10.1093/jnci/84.23.1836</identifier><identifier>PMID: 1433374</identifier><language>eng</language><publisher>United States: Oxford University Press</publisher><subject>Administration, Oral ; Etoposide - administration &amp; dosage ; Etoposide - therapeutic use ; Humans ; Sarcoma - drug therapy</subject><ispartof>JNCI : Journal of the National Cancer Institute, 1992-12, Vol.84 (23), p.1836-1837</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-4f7ab5cc49c03e0b33e5b907b6a73d015947923b0f9a02932eca10e7197496713</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1433374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KAMPE, CARSTEN E.</creatorcontrib><creatorcontrib>LOWENBRAUN, SUSAN</creatorcontrib><creatorcontrib>FOSTER, JANE</creatorcontrib><creatorcontrib>ROSEN, GERALD</creatorcontrib><title>Oral Etoposide in Treatment of Advanced Refractory Sarcomas</title><title>JNCI : Journal of the National Cancer Institute</title><addtitle>J Natl Cancer Inst</addtitle><subject>Administration, Oral</subject><subject>Etoposide - administration &amp; dosage</subject><subject>Etoposide - therapeutic use</subject><subject>Humans</subject><subject>Sarcoma - drug therapy</subject><issn>0027-8874</issn><issn>1460-2105</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1LAzEQhoMotVbPnoQ9eds2yWQ3GzyVUq1YKLYVxEvIZmdh637UZCv237ulRecyh_eZF-Yh5JbRIaMKRpvaFqNEDDkMWQLxGekzEdOQMxqdkz6lXIZJIsUlufJ-Q7tRXPRIjwkAkKJPHhbOlMG0bbaNLzIMijpYOzRthXUbNHkwzr5NbTELlpg7Y9vG7YOVcbapjL8mF7kpPd6c9oC8PU7Xk1k4Xzw9T8bz0IJkbShyadLIWqEsBaQpAEapojKNjYSMskgJqTikNFeGcgUcrWEUJVNSqFgyGJD7Y-_WNV879K2uCm-xLE2Nzc5r2f0SC5504OgIWtd47zDXW1dUxu01o_qgSx906URoDvqgq7u4O1Xv0gqzf_7op8vDY174Fn_-YuM-dSxBRnr2_qFfV0uerGKuX-AXmeVz7g</recordid><startdate>19921202</startdate><enddate>19921202</enddate><creator>KAMPE, CARSTEN E.</creator><creator>LOWENBRAUN, SUSAN</creator><creator>FOSTER, JANE</creator><creator>ROSEN, GERALD</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921202</creationdate><title>Oral Etoposide in Treatment of Advanced Refractory Sarcomas</title><author>KAMPE, CARSTEN E. ; LOWENBRAUN, SUSAN ; FOSTER, JANE ; ROSEN, GERALD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-4f7ab5cc49c03e0b33e5b907b6a73d015947923b0f9a02932eca10e7197496713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Administration, Oral</topic><topic>Etoposide - administration &amp; dosage</topic><topic>Etoposide - therapeutic use</topic><topic>Humans</topic><topic>Sarcoma - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KAMPE, CARSTEN E.</creatorcontrib><creatorcontrib>LOWENBRAUN, SUSAN</creatorcontrib><creatorcontrib>FOSTER, JANE</creatorcontrib><creatorcontrib>ROSEN, GERALD</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>JNCI : Journal of the National Cancer Institute</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KAMPE, CARSTEN E.</au><au>LOWENBRAUN, SUSAN</au><au>FOSTER, JANE</au><au>ROSEN, GERALD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral Etoposide in Treatment of Advanced Refractory Sarcomas</atitle><jtitle>JNCI : Journal of the National Cancer Institute</jtitle><addtitle>J Natl Cancer Inst</addtitle><date>1992-12-02</date><risdate>1992</risdate><volume>84</volume><issue>23</issue><spage>1836</spage><epage>1837</epage><pages>1836-1837</pages><issn>0027-8874</issn><eissn>1460-2105</eissn><cop>United States</cop><pub>Oxford University Press</pub><pmid>1433374</pmid><doi>10.1093/jnci/84.23.1836</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8874
ispartof JNCI : Journal of the National Cancer Institute, 1992-12, Vol.84 (23), p.1836-1837
issn 0027-8874
1460-2105
language eng
recordid cdi_proquest_miscellaneous_73336428
source MEDLINE; Oxford University Press Journals Digital Archive Legacy
subjects Administration, Oral
Etoposide - administration & dosage
Etoposide - therapeutic use
Humans
Sarcoma - drug therapy
title Oral Etoposide in Treatment of Advanced Refractory Sarcomas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T23%3A50%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20Etoposide%20in%20Treatment%20of%20Advanced%20Refractory%20Sarcomas&rft.jtitle=JNCI%20:%20Journal%20of%20the%20National%20Cancer%20Institute&rft.au=KAMPE,%20CARSTEN%20E.&rft.date=1992-12-02&rft.volume=84&rft.issue=23&rft.spage=1836&rft.epage=1837&rft.pages=1836-1837&rft.issn=0027-8874&rft.eissn=1460-2105&rft_id=info:doi/10.1093/jnci/84.23.1836&rft_dat=%3Cproquest_cross%3E73336428%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73336428&rft_id=info:pmid/1433374&rfr_iscdi=true